PUBLISHER: DelveInsight | PRODUCT CODE: 1397178
PUBLISHER: DelveInsight | PRODUCT CODE: 1397178
Total Ankle Replacement Market By Design Type (Scandinavian Total Ankle Replacement, Salto Total Ankle Replacement, Box Total Ankle Replacement, Zenith Total Ankle Replacement, Hintegra Total Ankle Replacement, Mobility Total Ankle Replacement, And Others), End-User (Hospitals And Clinics, Specialty Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of orthopedic diseases and the growing geriatric population across the globe.
The global total ankle replacement market is estimated to grow at a CAGR of 6.1% during the forecast period from 2023 to 2028. The demand for total ankle replacement is primarily being boosted by the growing prevalence of osteoarthritis, rheumatoid arthritis, and other orthopedic diseases. The increasing geriatric population base, increasing preference for total ankle replacement (TAR) over ankle fusion, development of efficient and advanced technology, rise in awareness among people, and rising new product launches and approvals, among others, are some of the key factors thereby contributing to the overall growth of the total ankle replacement market during the forecast period from 2023-2028.
According to the World Health Organization (WHO) 2023, in 2019, 18 million people worldwide were living with rheumatoid arthritis. About 70% of people living with rheumatoid arthritis were women, and 55% were older than 55 years. Arthritis can cause pain and stiffness in any joint in the body and is common in the small joints of the foot and ankle. This condition is expected to increase the demand for ankle replacement due to chronic ankle pain, thereby propelling the overall market growth.
Further, according to WHO 2023, till February 2020, around 20-50 million people suffered from non-fatal injuries, some resulted into bone fracture, and consecutively underwent ankle arthroplasty and other bone surgeries, thereby leading to an increased demand for total ankle replacement devices in the market.
In addition, rising strategic activities such as launches, approvals, acquisitions, and partnerships, by key players will also propel the overall market growth of total ankle replacement in the upcoming years. For instance, in February 2020, the United States Food and Drug Administration approved In2Bones Global Quantum Total Ankle for commercialization. The new total ankle replacement system treats patients who suffer from arthritis and is designed to improve patient mobility, increase stability, and technologically advance implant placement based on patient-specific anatomy. Therefore, the above-mentioned factors are contributing to the growth of the total ankle replacement market during the forecast period from 2023-2028.
However, risks associated with total ankle replacement surgery, stringent regulatory procedures, and others may restrict the total ankle replacement market growth.
Total Ankle Replacement Market by Design Type (Scandinavian Total Ankle Replacement, Salto Total Ankle Replacement, Box Total Ankle Replacement, Zenith Total Ankle Replacement, Hintegra Total Ankle Replacement, Mobility Total Ankle Replacement, and Others), End-User (Hospitals And Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World)
In the design type segment of the total ankle replacement market, the Hintegra total ankle replacement category is expected to amass a significant revenue share in the year 2022. This was primarily owing to the advantages and applications offered by the segment.
The HINTEGRA prosthesis is a three-part, non-constrained device that consists of a mobile bearing constructed of ultra-high molecular weight polyethylene, a talar component, and a tibial component that allows for normal flexion-extension mobility as well as axial rotation.
The prosthesis is used for various ankle-related issues such as ankle chronic pain, ankle arthritis, end-stage ankle osteoarthritis, and others.
Hintegra® Total Ankle Replacement by Allerga is an example of the study segment. It is a CoCr with double coated surface (porous Titanium and HAP) for optimal bone ingrowth.
Thus, the above-mentioned factors are likely to propel the demand for nanoparticles, thereby contributing to the growth of the Total Ankle Replacement market during the forecast period from 2023-2028.
Among all the regions, North America is estimated to account for the largest share of the Total Ankle Replacement market in the year 2022. This domination is due to the increasing prevalence of ankle arthritis, and osteoarthritis disorders along with higher demand for total ankle arthroplasty in place of arthrodesis, high awareness among the people regarding ankle treatment, presence of well-established healthcare infrastructure, availability of reimbursements, and high healthcare spending among others will propel the market of total ankle replacement in North America.
For instance, 5.9 million adult Canadians had arthritis in 2020, according to Statistics Canada 2021. Age-related increases in arthritis prevalence are more common in women.
In addition, almost one in four American adults (23.7%), or 58.5 million people, have arthritis as determined by a physician, according to the data from Centers for Disease Control and Prevention (CDC) updated in October 2021. Similarly, the Government of Canada estimates that in September 2020, 374,000 (1.2%) Canadians aged 16 and older have rheumatoid arthritis.
Further, the rising product launches, approvals, and others will propel the market in the region. For instance, in July 2020, Vilex, LLC acquired DT MedTech, LLC along with its product line including Hintermann Series System Total Ankle Replacement (TAR). The TAR system includes the Hintermann Series H3 (H3) 3-piece, mobile-bearing TAR prosthesis. Under this acquisition, DT MedTech continued to manufacture all its products under the DT MedTech Quality System and market its products outside the United States through its existing distribution network, and the Hintermann Series System will be supported in the United States through the sales organization of Vilex.
Also, in December 2022, Enovis Corporation, an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System) for use with the Company's STAR® total ankle replacement system.
Thus, all the above-mentioned factors will lead to an increase in the North America total ankle replacement market growth during the forecasting period of 2023-2028.
Some of the key market players operating in the total ankle replacement market include: Zimmer Biomet, Smith & Nephew, Exactech, Inc., Colfax Corporation, VILEX LLC., CONMED Corporation, restor3d., Allegra, Wright Medical Group N.V., Integra LifeSciences, Enovis, and others.